Home » Archive

Articles in the Diabetes Category

Diabetes »

[15 Feb 2012 | Comments Off | ]

Are you between the ages of 50 and seventy five years outdated and wish a life insurance? Over 50s life insurance coverage cowl is straightforward and straightforward to obtain. Life insurance coverage for over 50s is being provided by many life insurance companies within the US, Canada and the UK. In the UK, residents age 50 to eighty can get them in some corporations with low value premiums which might be assured by no means to rise. This are principally provided with entire life insurance coverage type.Most of the coverage …

Diabetes »

[14 Feb 2012 | Comments Off | ]

A properly planned diet regime is definitely an necessary part of diabetic patient’s lifestyle. Suitable controlled diet regime with satisfactory physical exercise helps in highest handle more than diabetes. As per the report made by American diabetes association, someone with diabetes should intake meals with fifty percent carbohydrate content material, thirty percent fat material and twenty percent protein content material. Uncontrolled consumption of food final results in overweight in the body there by rising the opportunity of hyperglycemia. More than consumption of oily food is one particular among the vital …

Diabetes »

[24 Jan 2012 | Comments Off | ]

What do you look for in the coffeemaker? Have you been looking for the best blend of coffee that should kick start your mornings? Being a coffee lover, you know there are a lot of components that go into making the right coffee blend.
To start with, you need to brew the correct type of coffee; the temperature of the water has to be perfect and, if you prefer, the sweetener and milk or creamer needs to be the perfect mix. Attempting to get all this perfect in the …

Diabetes, Drug Discovery, Headline, discovery »

[9 Sep 2010 | No Comment | ]

Advinus Therapeutics, the research-based pharmaceutical company promoted by the TATA Group has discovered a novel molecule for the treatment of type II diabetes – GKM -001. The molecule is an activator of glucokinase; an enzyme that regulates glucose balance and insulin secretion in the body.
GKM-001 is the completely indigenously developed molecule and the initial clinical trials have shown excellent results for both safety and efficacy.
“Considering past failures of other companies on this target, our discovery program primarily focused on identifying a molecule that would be efficacious without causing hypoglycemia. The Phase I data indicate that GKM – 001 is a liver selective molecule that has overcome the biggest clinical challenge of hypoglycemia. GKM-001 is differentiated from most other GK molecules in development due to this novel mechanism of action,” said Dr. Rashmi Barbhaiya, MD & CEO, Advinus Therapeutics.

Cancer, Diabetes, Headline, Health, Research, Science »

[12 Mar 2010 | No Comment | ]

Alterations in our response to the taste or smell of food may be another culprit responsible for type 2 diabetes, according to scientists at Duke University Medical Center who have identified the specific mechanism in human specimens and in mice. When we anticipate or smell a meal, the parasympathetic nervous system triggers salivation and increases insulin production in response to the expectation that glucose will be entering the blood stream. “We think this parasympathetic response is potentially important in type 2 diabetes,” said Vann Bennett, the James B.

Cancer, Diabetes, Headline, Health, Research, Science, Technology »

[9 Mar 2010 | No Comment | ]
 

By Kim McDonald Chlamydomonas reinhardtii is used widely as a genetic model organism. Credit: Beth Rasala, UCSD Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae—rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels. That’s the conclusion of a study, published online this week in Plant Biotechnology Journal, which sought to determine whether seven diverse human therapeutic proteins could be produced in Chlamydomonas reinhardtii, a green alga used widely in biology laboratories as a genetic model organism, much like the fruit fly Drosophila and the bacterium E. coli. “What surprised us was that of the seven genes chosen, four expressed proteins at levels sufficient for commercial production,” said Stephen Mayfield, a professor of biology at the University of California, San Diego who headed the study, which involved scientists at The Scripps Research Institute, San Diego biofuel company Sapphire Energy and ProtElix, a protein engineering company in Hayward, CA. UC San Diego researchers found this alga, seen from the neck of this flask, can also produce human therapeutic proteins.